JournalsHub
.online
Find My Journal
PC

Patricia Cortazar

Independent Researcher

ORCID iD 0009-0007-8515-8083
69
Publications
7,834
Citations
26
H-Index
34
i10-Index
6.5
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

69 total

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma PDF

Kanwal Raghav, Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl et al. - Cancer Discovery, 2021
Cited by 71 OpenAlex

Exposure–Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast Cancer

J Wang, Pengfei Song, Sarah J. Schrieber, Q Liu, Qiang Xu et al. - Clinical Pharmacology & Therapeutics, 2014
Cited by 65 OpenAlex

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC) PDF

Martin H. Cohen, Patricia Cortazar, Robert Justice, Richard Pazdur - The Oncologist, 2010
Cited by 55 OpenAlex

Research Topics

Breast Cancer Treatment Studies (30) Cancer Treatment and Pharmacology (25) HER2/EGFR in Cancer Research (23) Advanced Breast Cancer Therapies (15) Cancer Genomics and Diagnostics (10)

Affiliations

Roche (United States)
US 2023 - 2023
Allegheny Health Network
US 2019 - 2019
Naval Medical Research Command
US 1997 - 1997
United States Food and Drug Administration
US 2020 - 2009
Center for Drug Evaluation and Research
US 2015 - 2010

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now